Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.6B | 3.4B | 3.6B | 3.5B |
Cost of revenue | 2.6B | 2.4B | 2.6B | 2.6B |
Gross profit | 986M | 936M | 979M | 924M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 78M | 139M | 96M | 95M |
Operating income | 269M | 34M | 271M | 216M |
Non operating interest income | ||||
Income | 22M | 30M | 29M | 11M |
Expense | 57M | 53M | 63M | 64M |
Other income expense | — | — | — | — |
Pretax income | 384M | -292M | 374M | 37M |
Tax provision | 89M | -2M | 87M | 34M |
Net income | 295M | -290M | 286M | 3M |
Basic EPS | 0.6 | -0.6 | 0.6 | 0.0 |
Diluted EPS | 0.6 | -0.6 | 0.6 | 0.0 |
Basic average shares | 509.5M | 509.5M | 509.5M | 509.5M |
Diluted average shares | 509.5M | 509.5M | 509.5M | 509.5M |
EBITDA | 692M | 82M | 684M | 363M |
Net income from continuing op. | 384M | -292M | 374M | 37M |
Minority interests | -1M | 0 | -2M | -2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |